LitCovid-sample-Enju  

PMC:7205724 / 25278-25897 JSONTXT 23 Projects

Annnotations TAB TSV DIC JSON TextAE

Id Subject Object Predicate Lexical cue
T35160 0-3 DT denotes The
T65117 4-9 NN denotes study
T45353 10-11 -LRB- denotes [
T58501 11-13 CD denotes 31
T88016 13-14 -RRB- denotes ]
T88407 15-23 VBD denotes included
T16300 24-26 CD denotes 46
T33446 27-35 NNS denotes patients
T87886 36-40 IN denotes with
T58994 41-47 JJ denotes severe
T97970 48-56 NN denotes COVID-19
T41758 56-57 -COMMA- denotes ,
T58135 58-60 IN denotes of
T85647 61-66 DT denotes these
T95602 67-69 CD denotes 26
T73561 70-78 NNS denotes patients
T76496 79-87 VBD denotes received
T42976 88-106 NN denotes methylprednisolone
T32544 107-108 -LRB- denotes (
T60914 108-119 NN denotes 1–2 mg/kg/d
T95632 120-123 IN denotes for
T23094 124-132 NNS denotes 5–7 days
T28841 132-133 -RRB- denotes )
T83750 133-134 -COMMA- denotes ,
T5759 135-138 CC denotes and
T23681 139-141 CD denotes 20
T13615 142-150 NNS denotes patients
T96732 151-159 VBD denotes received
T97501 160-168 JJ denotes standard
T84414 169-176 NN denotes therapy
T2990 177-184 IN denotes without
T83484 185-203 NN denotes methylprednisolone
T55303 205-208 DT denotes The
T42547 209-214 JJ denotes first
T58218 215-220 NN denotes group
T37085 221-229 VBD denotes achieved
T74264 230-236 JJR denotes faster
T54798 237-248 NN denotes improvement
T77136 249-251 IN denotes in
T46765 252-260 JJ denotes clinical
T98040 261-269 NNS denotes symptoms
T23999 270-271 -LRB- denotes (
T37402 271-276 NN denotes fever
T65661 277-280 CC denotes and
T89758 281-291 JJ denotes peripheral
T63703 292-298 NN denotes oxygen
T9527 299-309 NN denotes saturation
T5300 309-310 -RRB- denotes )
T34896 311-314 CC denotes and
T9982 315-319 NN denotes lung
T64673 320-327 NNS denotes lesions
T90980 328-336 VBN denotes detected
T16483 337-339 IN denotes by
T31403 340-342 NN denotes CT
T8195 343-350 NN denotes imaging
T7710 352-359 RB denotes However
T57863 359-360 -COMMA- denotes ,
T19219 361-364 CD denotes two
T43356 365-371 NNS denotes deaths
T32769 372-380 VBD denotes occurred
T5412 381-383 IN denotes in
T52171 384-387 DT denotes the
T5683 388-393 JJ denotes first
T18985 394-399 NN denotes group
T72564 400-403 CC denotes and
T66890 404-407 CD denotes one
T21460 408-413 NN denotes death
T49866 414-416 IN denotes in
T26278 417-420 DT denotes the
T96270 421-427 JJ denotes second
T89439 428-433 NN denotes group
T61059 435-443 RB denotes Moreover
T97295 443-444 -COMMA- denotes ,
T66784 445-448 DT denotes the
T32526 449-452 CD denotes two
T39437 453-459 NNS denotes groups
T87016 460-463 VBD denotes did
T42838 464-467 RB denotes not
T18576 468-474 VB denotes differ
T50188 475-477 IN denotes in
T80686 478-488 NN denotes laboratory
T16685 489-499 NNS denotes parameters
T92910 499-500 -COMMA- denotes ,
T79314 501-510 VBG denotes including
T58552 511-514 NNP denotes WBC
T52445 514-515 -COMMA- denotes ,
T19300 516-526 NN denotes lymphocyte
T50601 527-532 NN denotes count
T15065 532-533 -COMMA- denotes ,
T27527 534-542 NN denotes monocyte
T31332 543-548 NN denotes count
T62470 548-549 -COMMA- denotes ,
T39782 550-553 CC denotes and
T74286 554-563 NNS denotes cytokines
T39990 564-565 -LRB- denotes (
T86188 565-569 NN denotes IL-2
T98181 569-570 -COMMA- denotes ,
T95707 571-575 NN denotes IL-4
T51521 575-576 -COMMA- denotes ,
T13191 577-581 NN denotes IL-6
T97649 581-582 -COMMA- denotes ,
T67884 583-586 CC denotes and
T96461 587-592 NN denotes IL-10
T46182 592-593 -RRB- denotes )
T71095 594-597 CD denotes six
T75519 598-602 NNS denotes days
T70281 603-608 IN denotes after
T58821 609-618 NN denotes treatment
R11494 T39437 T18576 arg1Of groups,differ
R11535 T98040 T34896 arg1Of symptoms,and
R12232 T15065 T39782 arg1Of ",",and
R12235 T13191 T51521 arg2Of IL-6,","
R12315 T73561 T85647 arg1Of patients,these
R12543 T5300 T23999 arg3Of ),(
R15075 T96461 T67884 arg2Of IL-10,and
R15972 T37402 T65661 arg1Of fever,and
R16309 T39437 T32526 arg1Of groups,two
R16819 T76496 T58135 arg1Of received,of
R16864 T58552 T52445 arg1Of WBC,","
R18127 T84414 T2990 arg1Of therapy,without
R19525 T16685 T79314 arg1Of parameters,including
R19610 T18985 T72564 arg1Of group,and
R20385 T33446 T88407 arg2Of patients,included
R2074 T32769 T5412 arg1Of occurred,in
R22355 T70281 T75519 arg1Of after,days
R22489 T65117 T45353 arg1Of study,[
R23329 T89439 T49866 arg2Of group,in
R2337 T41758 T5759 arg1Of ",",and
R24035 T54798 T74264 arg1Of improvement,faster
R24762 T84414 T96732 arg2Of therapy,received
R25227 T64673 T9982 arg1Of lesions,lung
R25309 T58218 T42547 arg1Of group,first
R2693 T54798 T37085 arg2Of improvement,achieved
R30779 T33446 T16300 arg1Of patients,46
R3470 T16685 T50188 arg2Of parameters,in
R35699 T88407 T41758 arg1Of included,","
R37097 T98040 T23999 arg1Of symptoms,(
R38432 T18576 T50188 arg1Of differ,in
R38992 T60914 T95632 arg1Of 1–2 mg/kg/d,for
R3939 T34896 T77136 arg2Of and,in
R3999 T64673 T90980 arg2Of lesions,detected
R40262 T60914 T32544 arg2Of 1–2 mg/kg/d,(
R42977 T32769 T57863 arg1Of occurred,","
R44220 T74286 T39782 arg2Of cytokines,and
R44421 T98040 T46765 arg1Of symptoms,clinical
R44574 T39782 T79314 arg2Of and,including
R44629 T42976 T76496 arg2Of methylprednisolone,received
R47378 T89439 T26278 arg1Of group,the
R47680 T9527 T89758 arg1Of saturation,peripheral
R48546 T67884 T97649 arg1Of and,","
R49171 T97970 T58994 arg1Of COVID-19,severe
R4945 T52445 T15065 arg1Of ",",","
R4977 T88016 T45353 arg3Of ],[
R50258 T13615 T96732 arg1Of patients,received
R51130 T31332 T27527 arg1Of count,monocyte
R51680 T31332 T15065 arg2Of count,","
R52418 T58218 T55303 arg1Of group,The
R53333 T58821 T70281 arg2Of treatment,after
R53455 T16685 T80686 arg1Of parameters,laboratory
R53458 T39437 T66784 arg1Of groups,the
R54057 T74286 T39990 arg1Of cytokines,(
R56134 T32769 T49866 arg1Of occurred,in
R5694 T58501 T45353 arg2Of 31,[
R58092 T8195 T16483 arg2Of imaging,by
R59428 T18985 T5683 arg1Of group,first
R60151 T21460 T66890 arg1Of death,one
R61252 T89439 T96270 arg1Of group,second
R6337 T86188 T98181 arg1Of IL-2,","
R63842 T54798 T77136 arg1Of improvement,in
R64586 T65117 T35160 arg1Of study,The
R65190 T13615 T23681 arg1Of patients,20
R65720 T5759 T83750 arg1Of and,","
R66219 T39782 T70281 arg1Of and,after
R66581 T28841 T32544 arg3Of ),(
R67482 T67884 T39990 arg2Of and,(
R67856 T72564 T5412 arg2Of and,in
R68253 T18576 T61059 arg1Of differ,Moreover
R68332 T9527 T65661 arg2Of saturation,and
R69030 T39782 T62470 arg1Of and,","
R69157 T39437 T87016 arg1Of groups,did
R70763 T8195 T31403 arg1Of imaging,CT
R72360 T51521 T67884 arg1Of ",",and
R72743 T18576 T87016 arg2Of differ,did
R72933 T50601 T19300 arg1Of count,lymphocyte
R73246 T32769 T7710 arg1Of occurred,However
R73275 T65661 T23999 arg2Of and,(
R73808 T21460 T72564 arg2Of death,and
R7566 T65117 T88407 arg1Of study,included
R75895 T84414 T97501 arg1Of therapy,standard
R76194 T42976 T32544 arg1Of methylprednisolone,(
R76205 T72564 T52171 arg1Of and,the
R76339 T18576 T42838 arg1Of differ,not
R77580 T9527 T63703 arg1Of saturation,oxygen
R78024 T95707 T98181 arg2Of IL-4,","
R78087 T43356 T32769 arg1Of deaths,occurred
R78424 T64673 T34896 arg2Of lesions,and
R81037 T18576 T97295 arg1Of differ,","
R81496 T50601 T52445 arg2Of count,","
R81532 T46182 T39990 arg3Of ),(
R81582 T65117 T76496 arg1Of study,received
R81725 T58218 T37085 arg1Of group,achieved
R85093 T23094 T95632 arg2Of 5–7 days,for
R85994 T83484 T2990 arg2Of methylprednisolone,without
R8712 T96732 T5759 arg2Of received,and
R87137 T73561 T58135 arg2Of patients,of
R8733 T8195 T90980 arg1Of imaging,detected
R89055 T98181 T51521 arg1Of ",",","
R90367 T73561 T95602 arg1Of patients,26
R90661 T16685 T92910 arg1Of parameters,","
R90696 T43356 T19219 arg1Of deaths,two
R93763 T76496 T41758 arg2Of received,","
R95770 T33446 T87886 arg1Of patients,with
R97198 T97970 T87886 arg2Of COVID-19,with
R98942 T75519 T71095 arg1Of days,six